Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sutro Biopharma Inc (NQ: STRO ) 2.890 -0.560 (-16.23%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sutro Biopharma Inc < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 07, 2024 Via Benzinga Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket November 07, 2024 Via Benzinga Peeling Back The Layers: Exploring Sutro Biopharma Through Analyst Insights October 11, 2024 Via Benzinga Analyst Expectations For Sutro Biopharma's Future September 16, 2024 Via Benzinga STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q2 2024 August 13, 2024 STRO stock results show that Sutro Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts May 08, 2024 Via Benzinga What's Going On With Sutro Biopharma (STRO) Stock? April 02, 2024 Sutro Biopharma shares are trading lower by 4.3% during Tuesday's session. The company announced the pricing of an underwritten offering. Via Benzinga Navigating 4 Analyst Ratings For Sutro Biopharma March 27, 2024 Via Benzinga Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 20, 2024 Via Benzinga Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday May 20, 2024 Via Benzinga Expert Ratings for Sutro Biopharma November 15, 2023 Via Benzinga Where Sutro Biopharma Stands With Analysts October 23, 2023 Via Benzinga 5 Analysts Have This to Say About Sutro Biopharma October 06, 2023 Via Benzinga Where Sutro Biopharma Stands With Analysts August 11, 2023 Via Benzinga STRO Stock Earnings: Sutro Biopharma Misses EPS, Beats Revenue for Q1 2024 May 13, 2024 STRO stock results show that Sutro Biopharma missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 28, 2024 Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... Via Benzinga REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday March 28, 2024 U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat... Via Benzinga 6 Analysts Have This to Say About Sutro Biopharma June 12, 2023 Via Benzinga Sutro Biopharma Earnings Perspective: Return On Capital Employed April 03, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 26, 2024 Via Benzinga STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q4 2023 March 25, 2024 STRO stock results show that Sutro Biopharma beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 30, 2023 Via Benzinga Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates November 27, 2023 From Vaxcyte, Inc. Via GlobeNewswire Where Sutro Biopharma Stands With Analysts March 31, 2023 Via Benzinga Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside October 06, 2023 Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 October 06, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Thursday September 21, 2023 During the session on Thursday, 461 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 During Tuesday's session, 275 companies made new 52-week lows. Via Benzinga Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 18, 2023 Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility. Via Benzinga Stocks That Hit 52-Week Lows On Friday August 11, 2023 During the Friday's sesion, 157 stocks hit new 52-week lows. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
